Nimesulide drug is a prescribed non-steroidal anti-inflammatory medication (NSAID) developed by Helsinn Healthcare with a multifactorial mode of action

Nimesulide is indicated for the treatment of acute pain and primary dysmenorrhoea.

Nimesulide has superior canal safety as compared to other NSAIDs. Food, gender and advanced age have negligible effects on Nimesulide pharmacokinetics.

It is available in a very form of forms like tablets, powder for dissolution in water, suppositories, mouth dissolving tablets and topical gel.

Clinical studies have been carried out in a wide variety of acute inflammatory and painful conditions with the aim of evaluating the analgesic activity of Nimesulide in comparison to placebo.

In the clinical studies the efficacy of nimesulide was consistently superior to placebo, to that observed for the reference drugs, with a particularly fast onset of the analgesic action.

The rapid analgesic activity shows reductions for the pain within 15 minutes from drug intake.